Current Editions
Propagating innovation should be central to U.K. growth strategy — Daniel Mahony
One of U.K. biotech’s premier figures discusses dilemma and opportunities for the U.K. and Europe in capturing value from their innovations
Finance
Data Byte
Replimune, Grace among biotechs with April PDUFA dates
After Orca delay, CBER still expected to rule on Replimune oncolytic virus
Discovery & Translation
Science Spotlight: Three teams converge on RNU2‑2 as targetable for neurodevelopmental epilepsies
Plus: LSD1 inhibition to restore erythropoiesis and four papers with links to new companies
Management Tracks
Shreehas Tambe becomes first CEO of newly combined Biocon
Plus: Moves at 4BIO Capital, Xaira and more
BioCentury ISSN 1097-7201